ATE132871T1 - Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor - Google Patents

Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor

Info

Publication number
ATE132871T1
ATE132871T1 AT89121680T AT89121680T ATE132871T1 AT E132871 T1 ATE132871 T1 AT E132871T1 AT 89121680 T AT89121680 T AT 89121680T AT 89121680 T AT89121680 T AT 89121680T AT E132871 T1 ATE132871 T1 AT E132871T1
Authority
AT
Austria
Prior art keywords
arylphosphatester
thrombocyte
antagonists
bis
activate factor
Prior art date
Application number
AT89121680T
Other languages
English (en)
Inventor
Allan Wissner
Kenneth Green
Robert Eugene Schaub
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE132871T1 publication Critical patent/ATE132871T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650905—Six-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
AT89121680T 1988-12-19 1989-11-23 Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor ATE132871T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/286,193 US4983592A (en) 1988-12-19 1988-12-19 Bis-arylphosphate ester antagonists of platelet activating factor

Publications (1)

Publication Number Publication Date
ATE132871T1 true ATE132871T1 (de) 1996-01-15

Family

ID=23097500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89121680T ATE132871T1 (de) 1988-12-19 1989-11-23 Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor

Country Status (21)

Country Link
US (2) US4983592A (de)
EP (1) EP0374513B1 (de)
JP (1) JP2733351B2 (de)
KR (1) KR0153279B1 (de)
AR (1) AR248027A1 (de)
AT (1) ATE132871T1 (de)
AU (1) AU623716B2 (de)
CA (1) CA2005678A1 (de)
DE (1) DE68925411T2 (de)
DK (1) DK170101B1 (de)
ES (1) ES2083964T3 (de)
FI (1) FI94348C (de)
GR (1) GR3018821T3 (de)
IE (1) IE74204B1 (de)
IL (1) IL92407A (de)
MX (1) MX9203270A (de)
NO (1) NO178305C (de)
NZ (1) NZ231724A (de)
PH (1) PH26906A (de)
PT (1) PT92595B (de)
ZA (1) ZA899695B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234918A (en) * 1988-04-04 1993-08-10 American Cyanamid Company Certain phosphinyl-oxy-phenyl-methyl-pyridinium-hydroxide inner salts useful as antagonists of PAF
US5215975A (en) * 1988-04-04 1993-06-01 American Cyanamid Company Certain hydroxy-phosphinyl-oxy-phenyl methyl-thiazolium hydroxide inner salts as PAF antagonists
US5231091A (en) * 1988-12-19 1993-07-27 American Cyanamid Company Bis-arylphosphate ester antagonists of platelet activating factor
US5147864A (en) * 1988-12-19 1992-09-15 American Cyanamid Company Bis-arylphosphate ester antagonists of platelet activating factor
US4983592A (en) * 1988-12-19 1991-01-08 American Cyanamid Co. Bis-arylphosphate ester antagonists of platelet activating factor
US5496855A (en) * 1995-01-27 1996-03-05 Smithkline Beecham Corp. Anti-inflammatory compounds
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7612668A (nl) * 1976-01-06 1977-07-08 Dow Chemical Co Werkwijze voor het bereiden van nieuwe organo- fosforusverbindingen.
US4091095A (en) * 1976-07-06 1978-05-23 Hoechst Aktiengesellschaft Phosphinyl compounds
US4316896A (en) * 1978-09-07 1982-02-23 Merck & Co., Inc. Aminoacid derivatives as antihypertensives
US4456464A (en) * 1982-05-19 1984-06-26 Zoecon Corporation Phenoxy- and pyridyloxy-phenoxyalkyl phosphinates and related sulfur compounds for weed control
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4640913A (en) * 1983-01-10 1987-02-03 American Cyanamid Company Phosphocholine derivatives having antihypertensive action
US4650791A (en) * 1984-01-11 1987-03-17 Takedo Chemical Industries, Ltd. Certain 3-alkoxy-2-cyclic-imido-propyl-phosphate-ethyl-cyclic ammonium hydroxide inner salts which inhibit activities of platelet activating factor
EP0178261A3 (de) * 1984-10-10 1986-12-30 Sandoz Ag Substituierte 2-Furanyl- oder -5-Oxo-2-furanyl-alkoxy-phosphorylalkylcyclimmoniumsalze
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
IT1178709B (it) * 1984-12-05 1987-09-16 Neopharmed Spa Diacilderivati della glicerilfosforilcolina ad attivita'terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
US4827011A (en) * 1984-12-10 1989-05-02 American Cyanamid Company Antihypertensive phosphate derivatives
US4900731A (en) * 1984-12-10 1990-02-13 American Cyanamid Company Antihypertensive phosphate derivatives
US4762942A (en) * 1984-12-10 1988-08-09 American Cyanamid Co. Antihypertensive phosphate derivatives
EP0225129B1 (de) * 1985-11-29 1989-05-24 Takeda Chemical Industries, Ltd. Phospholipidderivate, ihre Herstellung und ihre Verwendung
DE3626058A1 (de) * 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ES2096553T3 (es) * 1988-12-19 1997-03-16 American Cyanamid Co Metodo para el tratamiento de choque endotoxico en un animal mamifero.
US4983592A (en) * 1988-12-19 1991-01-08 American Cyanamid Co. Bis-arylphosphate ester antagonists of platelet activating factor
US5208223A (en) * 1990-11-13 1993-05-04 American Cyanamid Company Phosphocholine derivative inhibitors of phospholipase A2

Also Published As

Publication number Publication date
EP0374513A2 (de) 1990-06-27
AU4688389A (en) 1990-06-21
ES2083964T3 (es) 1996-05-01
MX9203270A (es) 1992-09-01
JPH02221291A (ja) 1990-09-04
DE68925411D1 (de) 1996-02-22
PT92595B (pt) 1996-06-28
FI896045A0 (fi) 1989-12-18
IE74204B1 (en) 1997-07-16
DK170101B1 (da) 1995-05-22
PH26906A (en) 1992-12-03
KR0153279B1 (ko) 1998-12-01
GR3018821T3 (en) 1996-04-30
FI94348B (fi) 1995-05-15
AR248027A1 (es) 1995-05-31
US4983592A (en) 1991-01-08
IE894058L (en) 1990-06-19
JP2733351B2 (ja) 1998-03-30
NO178305B (no) 1995-11-20
AU623716B2 (en) 1992-05-21
NZ231724A (en) 1992-09-25
NO178305C (no) 1996-02-28
DE68925411T2 (de) 1996-10-17
IL92407A0 (en) 1990-07-26
CA2005678A1 (en) 1990-06-19
IL92407A (en) 1995-12-31
EP0374513B1 (de) 1996-01-10
DK641989A (da) 1990-06-20
FI94348C (fi) 1995-08-25
US5328901A (en) 1994-07-12
NO895085L (no) 1990-06-20
EP0374513A3 (de) 1991-04-03
NO895085D0 (no) 1989-12-18
ZA899695B (en) 1990-09-26
PT92595A (pt) 1990-06-29
KR900009670A (ko) 1990-07-05
DK641989D0 (da) 1989-12-18

Similar Documents

Publication Publication Date Title
FI913251A0 (fi) Renad kiliarisk neurotrofisk faktor.
FI903947A0 (fi) Säiliö
FI902921A0 (fi) Nya pichia pastoris-stammar producerade genom interlocus rekombination.
DE68911939D1 (de) Beschichtungsvorrichtung.
FR2637622B1 (fr) Revetement
DK530888D0 (da) Leukotrien -ltd4- og - ltb4-antagonister
DE68909265D1 (de) DIP-Halterung.
DE68921665D1 (de) Hemmer vom flüssigen kalziumerhöhenden Faktor.
ATE132871T1 (de) Bis-arylphosphatester-antagonisten vom thrombocyten aktivierenden faktor
DE68922228T2 (de) Beschichtungsvorrichtung.
BR8803089A (pt) Recipiente
DK357989D0 (da) Kabelfoering af traadnet
DE68921529T2 (de) Beschichtungsvorrichtung.
FI880089A (fi) Päällystyslaite
ATA189788A (de) Schwerkraftsichter
FI891583A (fi) Nya antagonister av en blodplaettar aktiverande faktor.
FI930108A0 (fi) Imidazopyridin-paf-antagonister
DE68912248T2 (de) Diuretischer Faktor.
IT8967675A0 (it) Dispositivo di patinatura
FR2636921B1 (fr) Conteneur
DE68908538D1 (de) Thromboxan a2-antagonisten.
KR900009790U (ko) 방전가공기의 와이어 이탈방지장치
ATA168488A (de) Behaelter
KR900009144A (ko) 제품의 자동도포장치
GR3030543T3 (en) Platelet activating factor antagonists.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee